The role of ER-α36 and RUNX2 interaction in breast cancer progression

Jia Sun, Xin Guan, Hongyan Li, Xiaoxia Shi, Xiaozhen Fu, Bingqiang Zhang, Mengmeng Chen, Chao Qu, Wei Zou

Open source

DOI
10.1016/j.steroids.2026.109850
Published
2026-11
Container
Steroids
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.steroids.2026.109850,
  title = {The role of ER-α36 and RUNX2 interaction in breast cancer progression},
  author = {Jia Sun and Xin Guan and Hongyan Li and Xiaoxia Shi and Xiaozhen Fu and Bingqiang Zhang and Mengmeng Chen and Chao Qu and Wei Zou},
  year = {2026},
  journal = {Steroids},
  doi = {10.1016/j.steroids.2026.109850},
  url = {https://doi.org/10.1016/j.steroids.2026.109850}
}

RIS

TY  - JOUR
TI  - The role of ER-α36 and RUNX2 interaction in breast cancer progression
AU  - Jia Sun
AU  - Xin Guan
AU  - Hongyan Li
AU  - Xiaoxia Shi
AU  - Xiaozhen Fu
AU  - Bingqiang Zhang
AU  - Mengmeng Chen
AU  - Chao Qu
AU  - Wei Zou
PY  - 2026
JO  - Steroids
DO  - 10.1016/j.steroids.2026.109850
UR  - https://doi.org/10.1016/j.steroids.2026.109850
ER  - 

APA

Sun, J., Guan, X., Li, H., Shi, X., Fu, X., Zhang, B., Chen, M., Qu, C., & Zou, W. (2026). The role of ER-α36 and RUNX2 interaction in breast cancer progression. Steroids. https://doi.org/10.1016/j.steroids.2026.109850

Source records